familymednews.com
Glioma is the most common type of primary malignant brain tumor in the United States; glioblastoma being the most common type of glioma in adults. While sex differences in the incidence and survival rates of glioma were known, researchers had not investigated whether genetic differences based on sex could cast light on potential differences in the risk profile of glioma […]
Continue reading »
(HealthDay)—Can you spell words backwards while you’re walking? Successfully performing that simple test of cognition could help decide whether a concussed athlete is safe to return to play, new research shows. If the athlete can’t simultaneously walk and think in this way, they may not be fully recovered from a concussion and could be at risk for another injury if […]
Continue reading »
Although it’s far from perfect by virtually any measure—whether poverty rates, violence, access to education, racism and prejudice or any number of others—the world continues to improve. Why, then, do polls consistently show that people believe otherwise? The answer, Daniel Gilbert says, may lie in a phenomenon called “prevalence induced concept change.” As demonstrated in a series of new studies, […]
Continue reading »
(HealthDay)—For patients who experienced a transient ischemic attack (TIA) or minor stroke, the rate of a composite of stroke, acute coronary syndrome, or death from cardiovascular causes is 12.9 percent at five years, with half of these events occurring in the second through fifth years, according to a study published June 7 in the New England Journal of Medicine. Pierre […]
Continue reading »
NEW YORK, June 14, 2018 (GLOBE NEWSWIRE) — Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced the completion of its rolling submission of a New Drug Application (NDA) to the U.S. Food & Drug Administration (FDA) for iclaprim, a targeted, Gram-positive investigational antibiotic, for the treatment of acute bacterial skin and skin […]
Continue reading »
Unlike with alcohol or nicotine, there is not a pharmacological option available to individuals addicted to cocaine to help them stop using the drug. However, researchers at the University of Alabama at Birmingham believe the tool to help individuals treat their addiction may very well exist. Researchers in the School of Public Health are conducting a clinical trial to see […]
Continue reading »
Doctors have long known that separating families and other traumatic events can damage children’s well-being. More recent research has shed some light on how that may happen: Severe early adversity may cause brain changes and “toxic stress,” resulting in lasting psychological and physical health problems. A “zero-tolerance” immigration policy announced this spring by the Trump Administration has separated 2,300 children […]
Continue reading »
A device under development at the Department of Energy’s SLAC National Accelerator Laboratory and Stanford University could help bring back lost brain function by measuring how the brain responds to therapies that stimulate it with electric current. The approach could open new avenues for treating brain disorders and selectively switching brain activities on and off, says Anthony Norcia, a professor […]
Continue reading »
University of Queensland researchers have discovered how to reverse drug resistance in skin and mouth squamous cell carcinomas. UQ Diamantina Institute Associate Professor Nicholas Saunders said squamous cell carcinomas was curable when diagnosed early but difficult to eradicate once the cancer spread. “This cancer of the skin and mouth kills approximately 1,400 Australians each year,” Dr. Saunders said. “The drugs […]
Continue reading »
Patients who have a penicillin allergy recorded in their medical records are at an increased risk of developing the drug resistant ‘superbug’ infection MRSA and healthcare-associated infection C difficile, finds a study published by The BMJ today. The risk is largely due to the use of more ‘broad spectrum’ antibiotics as alternatives to penicillin, which may be fuelling the development […]
Continue reading »